Marja Nevalainen, M.D., Ph.D., Associate Professor of Cancer Biology, Medical Oncology and Urology a

Caption: Stat5 could serve as a biomarker to help guide prostate cancer treatment, say Jefferson’s Kimmel Cancer Center researchers.

Credit: TJU

Usage Restrictions: None

Related news release: Stat5 predicts outcomes for prostate cancer patients after radical prostatectomy